stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) EV/FCF
As of 6 November 2026, Clover Health Investments, Corp. (CLOV) trades at a EV/FCF of 17.5×. Over the past ten years it has ranged from −200× (May 2025) to 64.9× (January 2025); the current reading is higher than 89% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | −16.0× | — |
| FY2024 | 40.4× | — |
| FY2023 | −1.7× | — |
| FY2022 | −0.7× | — |
| FY2021 | −3.4× | — |
| FY2020 | −12.7× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 15.6× | (54.02%) |
| Jun 2026 | 34.0× | 151.81% |
| Mar 2026 | 13.5× | — |
| Dec 2025 | −16.0× | — |
| 23 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| OSCR Oscar Health, Inc. compare | 1.3× |
| CNC Centene Corporation compare | 6.7× |
| CI Cigna Group compare | 12.3× |
| HUM Humana Inc. compare | 12.5× |
| ELV Elevance Health, Inc. compare | 13.1× |
| PGNY Progyny, Inc. compare | 13.7× |
| ALHC Alignment Healthcare, Inc. compare | 14.4× |
| CLOV Clover Health Investments, Corp. | 17.5× |
| MOH Molina Healthcare, Inc compare | 25.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement